Global Pet Cancer Therapeutics Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 283.86 Million |
 Market Size (Forecast Year) |
USD 569.77 Million |
 CAGR |
% |
| Major Markets Players |
|
全球宠物癌症治疗市场，按疗法（化疗、放射疗法、免疫疗法、靶向疗法、联合疗法等）、药物类型（化疗药物和疫苗）、给药途径（肠外、口服等）、癌症类型（黑色素瘤、肥大细胞癌、淋巴瘤、乳腺癌和鳞状细胞癌等）、物种类型（猫、狗等）、最终用户（兽医医院和临床药房、零售药房、网上药房等）划分 - 行业趋势和预测到 2031 年。
宠物癌症治疗市场分析和规模
宠物癌症治疗市场发展迅速，最新方法和技术推动了增长。靶向疗法和免疫疗法等创新正在改变治疗方法。宠物医疗支出的增加和宠物寿命的延长促进了市场扩张。公司专注于精准医疗和个性化治疗，以提高宠物癌症治疗的疗效和效果。
2023 年全球宠物癌症治疗市场规模为 2.8386 亿美元，预计到 2031 年将达到 5.6977 亿美元，预测期内（2024 年至 2031 年）的复合年增长率为 9.10%。这表明市场价值。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022 (可定制为 2016-2021) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
治疗（化疗、放疗、免疫治疗、靶向治疗、联合治疗等）、药物类型（化疗药物和疫苗）、给药途径（肠外、口服等）、癌症类型（黑色素瘤、肥大细胞癌、淋巴瘤、乳腺癌和鳞状细胞癌等）、物种类型（猫、狗等）、最终用户（兽医医院和临床药房、零售药房、网上药房等） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区。 |
|
涵盖的市场参与者 |
AB Science (France), Elanco (U.S.), Candel Therapeutics (Canada), NIPPON ZENYAKU KOGYO CO., LTD. (Japan), Rhizen Pharmaceuticals AG (Switzerland), Virbac Corporation (France), Pfizer Inc. (U.S.), VetDC (U.S.), Boehringer Ingelheim International GmbH (Germany), Karyopharm (U.S.), VETCO (U.S.), ELIAS Animal Health (U.S.), Vivesto AB (Sweden), Torigen Pharmaceuticals Inc. (U.S.), and Zoetis Services LLC (U.S.) |
|
Market Opportunities |
|
Market Definition
Pet cancer therapeutics refer to treatments and medications designed to diagnose, manage, and potentially cure cancer in animals. These therapies include chemotherapy, surgery, radiation, and targeted therapies tailored to specific types of cancer in pets. The goal is to improve quality of life, extend survival, and minimize pain and discomfort associated with cancer in dogs, cats, and other companion animals.
Pet Cancer Therapeutics Market Dynamics
Drivers
- Increasing Pet Ownership
Increasing pet ownership globally has led to heightened awareness and increased spending on pet healthcare, significantly boosting demand for advanced therapies in the pet cancer therapeutics market. For instance, as more households treat pets as family members, there's a greater willingness to invest in treatments such as cancer therapies, driving market growth. This trend is supported by a growing number of veterinary clinics offering specialized oncology services tailored to meet the needs of pet owners seeking advanced healthcare options.
- Advancements in Veterinary Medicine
Advancements in veterinary medicine, particularly in oncology, are driving growth in the pet cancer therapeutics market. For instance, new treatment modalities such as targeted therapies and immunotherapies offer more effective and less invasive options for treating cancer in pets. Additionally, advanced diagnostic technologies such as molecular imaging and genetic testing enable earlier detection and personalized pet cancer treatment approaches, improving outcomes and fostering higher demand for specialized veterinary oncology services and products.
Opportunities
- Regulatory Support and Guidelines
Clearer regulatory frameworks and guidelines are pivotal in driving the pet cancer therapeutics market by ensuring safer and more effective treatments. For instance, the FDA's Center for Veterinary Medicine (CVM) provides guidance on drug approval processes, ensuring products meet safety and efficacy standards. Such frameworks encourage investment in research and development, fostering innovation in treatments tailored to pets' specific cancer types, ultimately expanding treatment options and improving outcomes for companion animals.
- Improved Diagnostic Capabilities
Improved diagnostic capabilities in veterinary oncology have significantly enhanced early detection and treatment planning for pet cancers. Advanced imaging techniques such as CT scans and MRI, alongside genetic testing for biomarker identification, allow veterinarians to diagnose cancers earlier and tailor treatments more effectively. For instance, the use of next-generation sequencing helps identify specific mutations in tumors, guiding targeted therapies. This capability not only improves outcomes but also drives growth in the pet cancer therapeutics market by promoting timely and personalized treatment strategies.
Restraints/Challenges
- High Cost of Treatment
The high cost of cancer treatment for pets acts as a significant barrier, restricting access for many owners and thereby hindering market growth. The expense involved often deters potential customers from pursuing such treatments, impacting market expansion negatively. This financial constraint limits the market's potential reach and adoption among pet owners, creating a substantial hurdle for companies operating in the pet cancer therapeutics sector.
- Complexity of Treatment
Administering and monitoring cancer treatments in pets poses significant challenges due to their diverse physiology and behavioral variations. This complexity hinders market growth by complicating treatment efficacy and consistency. Veterinarians face difficulties in standardizing care across different animal species and breeds, impacting treatment outcomes. These inherent differences contribute to the overall complexity and unpredictability of managing cancer therapies in pets, creating barriers to market expansion.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In July 2022, Fort Wayne Animal Care and Control received a USD 35,000 grant from Petco Love to bolster their efforts in saving animal lives in Fort Wayne. This funding aims to enhance their capacity for animal welfare initiatives, including adoption programs and veterinary care
- In June 2022, Petco Love allocated USD 75,000 grant to Cornell University College of Veterinary Medicine. This long-standing partnership supports subsidized cancer treatments for dogs and cats, advancing veterinary oncology research and care
- In June 2022, Boehringer Ingelheim and CarthroniX embarked on a collaboration to innovate canine oncology. They aim to pioneer novel small molecule therapies for aging-related and degenerative diseases in dogs, potentially expanding Boehringer Ingelheim's Animal Health portfolio
Pet Cancer Therapeutics Market Scope
The market is segmented on the basis of therapy, medicine type, route of administration, cancer type, species type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Therapy
- Chemotherapy
- Radiation Therapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- Others
Medicine Type
Route of Administration
- Parenteral
- Oral
- Others
Cancer Type
- Melanoma
- Mast Cell Cancer
- Lymphoma
- Mammary and Squamous Cell Cancer
- Others
Species Type
- Cat
- Dog
- Others
End User
- Veterinary Hospitals and Clinical Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Pet Cancer Therapeutics Market Regional Analysis/Insights
The market is analysed and market size insights and trends are provided by country, therapy, medicine type, route of administration, cancer type, species type and end user as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to dominate the pet cancer therapeutics market due to rising prevalence, robust healthcare infrastructure, and significant research investments. These factors contribute to its leading position in advancing treatments for pets diagnosed with cancer.
Asia-Pacific is expected to expand at a significant growth in the pet cancer therapeutics market due to increasing incidence, awareness, government initiatives, and disposable incomes in the region, fostering market expansion over the forecast period.
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
该市场还为您提供每个国家/地区资本设备医疗支出增长、市场上不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对市场的影响的详细市场分析。数据适用于 2016-2021 年的历史时期。
竞争格局和宠物癌症治疗市场份额分析
市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
市场上的一些主要参与者包括：
- AB 科学（法国）
- Elanco (美国)
- Candel Therapeutics（加拿大）
- 日本全药工业株式会社（日本）
- Rhizen Pharmaceuticals AG（瑞士）
- Virbac 公司（法国）
- 辉瑞公司（美国）
- VetDC（美国）
- 勃林格殷格翰国际有限公司 (德国)
- Karyopharm (美国)
- VETCO (美国)
- ELIAS 动物保健（美国）
- Vivesto AB（瑞典）
- Torigen Pharmaceuticals Inc.（美国）
- Zoetis Services LLC（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
